Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
41 /100
MEDIUM RISK
Score updated Oct 13, 2026

DFTX — Definium Therapeutics, Inc. Dilution Risk Tracker

Track DFTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DFTX — Get alerts when the score changes →

As of October 13, 2026, Definium Therapeutics, Inc. (DFTX) has a DilutionWatch DilutionScore of 41/100, rated MEDIUM dilution risk. Definium Therapeutics, Inc. has a market capitalization of $4.73B, 134.37M shares outstanding, 12 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for DFTX.
🔔 Track DFTX — Get forecast alerts →

Market Data

Market Cap$4.73B
Shares Outstanding134.37M
Float108.17M
Cash$1.08B
Debt$36.47M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore41/100DilutionWatch score record
Shares Outstanding134.37MVerified float table or market cache
Public Float108.17MVerified float table or market cache
Market Cap$4.73BMarket data cache
Cash Runway127.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 84.6% shares (2026Q1 vs prior)
12 institutional holders · 9.07M shares
#1 Avoro Capital Advisors LLC 5.00M shares
#2 Candriam S.C.A. 971.2K shares
#3 GOLDMAN SACHS GROUP INC 925.3K shares
+ 9 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest11.34M
Days to Cover4.9
% of Float10.5%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-02-26
4 INSIDER TRANSACTION 2026-03-26
4 INSIDER TRANSACTION 2026-03-26
4 INSIDER TRANSACTION 2026-02-05
4 INSIDER TRANSACTION 2026-02-05
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual DFTX Dilution Snapshot

Definium Therapeutics, Inc. (DFTX) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

DFTX's DilutionScore is currently 41/100 (Medium risk), with 4 score changes tracked over 89 days. The score improved from 40/100 (Medium risk).

Period Score Risk Level Duration
Sep 30 – Oct 13, 202641/100MEDIUM14 days
Aug 22 – Sep 29, 202640/100MEDIUM39 days
Aug 14 – Aug 21, 202638/100MEDIUM7 days
Jul 17 – Aug 13, 202639/100MEDIUM28 days
Jul 16, 202638/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

DFTX shares outstanding have increased 12.2% from 97.22M (Mar 2026) to 109.07M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 2026109.07M108.17M▲ 0.11%
May 12, 2026109.07M108.06M▲ 9.40%
May 08, 2026109.07M98.77M▲ 5.43%
Apr 11, 202699.70M93.69M▼ 0.05%
Mar 05, 202697.22M93.74M▲ 0.06%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track DFTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment DFTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking DFTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for DFTX
DFTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.